- A study of thymidylate synthase expression as a biomarker for resectable colon cancer: Alliance (cancer and Leukemia group B) 9581 and 89803. Oncologist. 2017 Academic Article GET IT
An open-label, dose-escalation phase I study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma.
Clinical Cancer Research.
Times cited: 4
Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database.
Journal of Clinical Oncology.
Times cited: 22